NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 82 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $626,580 | -58.7% | 585,589 | +0.0% | 0.00% | -50.0% |
| Q2 2023 | $1,516,406 | +114.4% | 585,485 | +237.7% | 0.00% | +100.0% |
| Q1 2023 | $707,423 | +70642.3% | 173,388 | +17338700.0% | 0.00% | – |
| Q4 2021 | $1,000 | -99.3% | 1 | -100.0% | 0.00% | – |
| Q3 2021 | $139,000 | +5.3% | 6,628 | -0.7% | 0.00% | – |
| Q2 2021 | $132,000 | +238.5% | 6,678 | +175.4% | 0.00% | – |
| Q3 2020 | $39,000 | -26.4% | 2,425 | -9.5% | 0.00% | – |
| Q2 2020 | $53,000 | +29.3% | 2,681 | -18.9% | 0.00% | – |
| Q1 2020 | $41,000 | -41.4% | 3,306 | -12.7% | 0.00% | – |
| Q4 2019 | $70,000 | – | 3,787 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 18,136,735 | $237,228,000 | 52.50% |
| Ponoi II Management, LLC | 1,298,908 | $16,990,000 | 44.41% |
| Ponoi Management, LLC | 1,298,908 | $16,990,000 | 23.20% |
| Euclidean Capital LLC | 746,674 | $9,766,000 | 9.07% |
| StepStone Group LP | 1,573,357 | $20,580,000 | 2.93% |
| Logos Global Management LP | 850,000 | $11,118,000 | 1.37% |
| First Light Asset Management, LLC | 955,505 | $12,498,000 | 1.26% |
| GREAT POINT PARTNERS LLC | 316,256 | $4,137,000 | 1.00% |
| Rubric Capital Management LP | 877,161 | $11,473,000 | 0.58% |
| Avidity Partners Management LP | 1,798,100 | $23,519,000 | 0.48% |